https://ojs.acad-pub.com/index.php/MS <p><em><strong>Metabolic Studies&nbsp;</strong></em><strong>(MS)</strong> is an internationally peer-reviewed open-access journal. The journal conducts metabolic research in ten main sections:</p> <ul> <li class="show">Microbiology and ecological metabolomics</li> <li class="show">Bone metabolism</li> <li class="show">Plant metabolism</li> <li class="show">Endocrinology and clinical metabolism</li> <li class="show">Food metabolomics</li> <li class="show">Metabolic disorders research</li> <li class="show">Cellular metabolism</li> <li class="show">Lipid metabolism</li> <li class="show">Nutrition and metabolism</li> <li class="show">Pharmacology, and drug metabolism</li> </ul> <p>However, the journal is not limited to these ten sections and welcomes contributions from metabolic researchers and practitioners from around the world, which can be original research articles, review articles, editorials, cases, reports, reviews, etc.</p> Academic Publishing Pte. Ltd. en-US Metabolism Studies <p>Authors contributing to this journal agree to publish their articles under the<span> </span><a href="http://creativecommons.org/licenses/by/4.0" target="_blank">Creative Commons Attribution 4.0 International License</a>, allowing third parties to share their work (copy, distribute, transmit) and to adapt it <span lang="EN-US">for any purpose, even commercially, under the condition that the authors are given credit.</span> With this license, authors hold the copyright.</p><p><img src="https://esp.apacsci.com/public/site/images/reviewer/OIP-C.jpg" alt="" /></p> https://ojs.acad-pub.com/index.php/MS/article/view/270 <div>As an entomopathogenic fungus with significant</div><div>pharmacological and therapeutic implications, particularly for human</div><div>health, Cordyceps sp. is a good alternative for ethnopharmacological use.</div><div>A unique bio-metabolite termed Cordycepin (3′deoxyadenosine), which</div><div>has extremely significant anti-cancer, anti-oxidant, and</div><div>anti-inflammatory properties, is the main component of the extract</div><div>made from this fungus. Due to their diverse biological functions,</div><div>Cordyceps fungi have long drawn the interest of scientists; nonetheless, it</div><div>has been difficult to successfully isolate active monomer molecules from</div><div>them. Fungi produce significantly fewer substances in the lab than they</div><div>do in the wild. In this review, I go through recent discoveries about the</div><div>transcriptional and epigenetic control of BGCs as well as the ecological</div><div>functions of fungal secondary metabolites in development, defense, and</div><div>warfare. I also look at ways to find new fungal metabolites and the</div><div>difficulties associated with gathering secondary metabolites derived</div><div>from fungi. Metabolites serve a variety of purposes, including energy</div><div>production, structural support, signaling and modulation of enzyme</div><div>activity (often as an enzyme cofactor), defense, and interactions with</div><div>other organisms (such as the production of pigments, odorants, and</div><div>pheromones). Refocusing and reviving efforts to mine the fungal</div><div>secondary metabolome has been one of the most interesting</div><div>developments in the field of microbiology. Cordyceps sp., an</div><div>entomopathogenic fungus, is a potential ethnopharmacological source</div><div>due to its unique bio-metabolite, Cordycepin, which has anti-cancer,</div><div>anti-oxidant, and anti-inflammatory properties. Its potential</div><div>applications include immune system effects, DNA technology,</div><div>metagenomics, kidney and cardiovascular systems, and cancer</div><div>prevention in food and cosmetic industries.</div> Loknath Deshmukh Rupesh Thakur Aanchal Sonkuwar Sardul Singh Sandhu Copyright (c) 2023 Loknath Deshmukh, Rupesh Thakur, Aanchal Sonkuwar, Sardul Singh Sandhu https://creativecommons.org/licenses/by/4.0 2023-12-15 2023-12-15 1 1 https://ojs.acad-pub.com/index.php/MS/article/view/1193 <p>The review presents a comprehensive overview of the potential therapeutic advancements facilitated by microbial metabolites, particularly focusing on the symbiotic relationship between endophytic fungi and <em>Anogeissus latifolia</em> and related species. These fungi produce a diverse array of metabolites with pharmacological significance, including antibacterial, anticancer, antioxidant, and anti-diabetic properties. The review highlights the importance of endophytic fungi in natural drug discovery, emphasizing their role in enhancing plant resilience and producing therapeutically relevant compounds. Chemical analysis of A. latifolia reveals compounds like ellagic acid derivatives and flavonoids with medicinal potential, while pharmacological investigations showcase the plant’s efficacy in traditional applications and its promising antibacterial properties. Methodologies for identifying and characterizing bioactive compounds, such as metabolomics and high-performance thin chromatography, are outlined, supporting the hypothesis that undiscovered bio-metabolites from endophytic fungi hold high antibacterial potential, thus offering new avenues for drug discovery. In conclusion, the exploration of microbial metabolites, particularly those derived from endophytic fungi in A. latifolia, presents promising opportunities for developing novel, environmentally friendly, and effective therapies. This review underscores the significance of A. latifolia in herbal medicine and drug discovery, emphasizing the importance of preserving biodiversity and sustainable resource utilization.</p> Vibhuti Sabhlok Pavan Jain Shama J. P. Khanam Aanchal Sonkuwar Sardul Singh Sandhu Loknath Deshmukh Copyright (c) 2024 Vibhuti Sabhlok, Pavan Jain, Shama J. P. Khanam, Aanchal Sonkuwar, Sardul Singh Sandhu, Loknath Deshmukh http://creativecommons.org/licenses/by/4.0/ 2024-06-04 2024-06-04 1 1 1193 1193 10.59400/ms.v1i1.1193 https://ojs.acad-pub.com/index.php/MS/article/view/150 <p>N/A</p> Michael R. Hamblin Copyright (c) 2023 Michael R. Hamblin https://creativecommons.org/licenses/by/4.0 2023-09-14 2023-09-14 1 1